Skip to main content

Table 3 Reported adverse events in both under-fives and children aged 5-10 years

From: Therapeutic efficacy and safety of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in North-Eastern Tanzania

Adverse event Age groups Total
Under-fives (n = 51) Children aged ≥5 years (n = 28)
Cough 28(54.9%) 11(39.3%) 39(49.4%)
Fever 13(25.5%) 3(10.7%) 16(20.2%)
Abdominal pain 5(9.8%) 3(10.7%) 8(10.1%)
Diarrhoea 1(2.0%) 0(0%) 1(1.3%)
Headache 0(0%) 1(3.6%) 1(1.3%)
Skin rashes 1(2.0%) 0(0%) 1(1.3%)
None 3(5.9%) 10(35.7%) 13(16.5%)
Total 51(100%) 28(100%) 79(100%)